Lansoprazole
Product Images NDC 68196-045

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 68196-045). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sam's West Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (14ct 15mg Label)

Lansoprazole Delayed-Release Capsules USP 15 mg distributed by Sam's West Inc. The label indicates a 14-capsule package intended for a 14-day treatment course. The product is identified by NDC 68196-045-01 and is made in India. The label also includes tamper-evident information and directions for use, noting to take one capsule daily and other usage instructions.*

FDA Label Image

Principal Display Panel (42ct 15mg Stretch Card)

Packaging label for Member's Mark Lansoprazole 15 mg delayed-release capsules, USP. The label indicates 42 capsules per package, a value 3 pack size, and describes the product as an acid reducer. It includes a comparison to Prevacid 24-hour active ingredient and dosage instructions. The labeler is Sam's West Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.